Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

Discover the latest developments in the neuroplastogens field, including Elkedonia’s funding to address neuropsychiatric ...

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Paris is known for many things, from romance to art to world-beating croissants. But perhaps one of its lesser-known attributes is that it is a thriving hub for biotech and life sciences.In fact, the ...

Gilead Sciences has also entered the STAT6 degraders space. In January 2025, it struck a major deal with LEO Pharma worth up to $1.7 billion, including $250 million upfront, to develop an oral ...

The discovery of stem cell therapy. Although cell therapy was first performed in 1958 when French oncologist Georges Mathe transplanted bone marrow stem cells after six nuclear researchers were ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' ...

The excitement surrounding artificial intelligence (AI)’s potential to transform healthcare has led to substantial investments and a proliferation of startups eager to harness the power of machine ...